REQUEST MORE INFORMATION ABOUT YOSPRALA® (ASPIRIN AND OMEPRAZOLE)

Get the latest information about Yosprala—the only therapy designed to sequentially deliver immediate-release omeprazole and delayed-release aspirin (ASA) for patients who require ASA for secondary prevention of cardiovascular and cerebrovascular events and are at risk for developing ASA-associated gastric ulcers.1

Fill out the following form to receive product updates, including future offers.


Yosprala® is a registered trademark of Genus Lifesciences, Inc. and is used under license. All other product/brand names are trademarks of their respective owners.
Manufactured for: Innovida Pharmaceutique Corporation © 2019 Innovida Pharmaceutique Corporation, Inc. All rights reserved. INY-01-001, Rev 10/2019